Notably, there is a paucity of data to assess the impact on the BC risk of BBD in women classified as high-risk based on family history, PV carrier status in a cancer susceptibility gene (mainly BRCA1 and BRCA2), or polygenic risk score (PRS). The gene discussed is BRCA2; the disease is breast cancer.